ArticleProceedings of the National Academy of Sciences of the United States of America2002

Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors.

Thomas M J Niederman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.